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Abstract Glycolytic gene expression is mediated by the Gcr1p-
Gcr2p transcriptional activation complex. A screen for multicopy
suppressors of gcr2 yielded SGC1. SGC1’s suppression activity
was specific to gcr2, it did not extend to gcr1. Disruption of
SGC1 moderately affected glycolytic enzyme activities, although
no growth defect was evident. Sgc1p exhibits a bHLH motif
which is characteristic of E-box DNA-binding proteins. DNA
footprinting experiments demonstrated Sgc1p’s ability to bind at
an E-box. However, its binding specificity was less than 10-fold,
which is also characteristic of E-box binding proteins. LexA
fusion experiments demonstrated that Sgc1p has weak intrinsic
activating activity independent of GCR1 and GCR2. We propose
that Sgc1p binds at E-boxes of glycolytic genes and contributes
to their activation.
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1. Introduction
The glycolytic pathway is a major metabolic route in Sac-
charomyces cerevisiae. Most of the genes encoding glycolytic
enzymes are highly expressed [1]. The core UAS element of
glycolytic enzyme genes contains binding sites for Rap1p
(RPG-box) and Gcr1p (CT-box) [2]. The strong synergism
between the binding sites for Rap1p and Gcr1p [2^9] suggests
that both Rap1p and Gcr1p are intimately involved in glyco-
lytic gene expression. Since Rap1p is capable of carrying out
many diverse cellular functions such as activation and repres-
sion of transcription depending on the sequence context of its
binding site, it has been suggested that its function may be
determined by the interaction with other regulatory proteins
[10,11]. The role of Rap1p at glycolytic enzyme gene UAS
elements is to facilitate the binding of Gcr1p [9,12,13].
In addition to Rap1p, Gcr1p also acts with Gcr2p to medi-
ate high level of glycolytic gene expression. Uemura and Ji-
gami [14] presented genetic evidence for a physical interaction
of Gcr2p and Gcr1p and postulated that the function of
Gcr2p is to provide an activation domain to a Gcr1p-Gcr2p
complex. Consistent with this view the drastic reduction of
most glycolytic enzymes in gcr1 mutants is mirrored in gcr2
mutants [15]. Their further analysis provided genetic evidence
for a potential transcriptional activation function in Gcr1p
[16]. Hence, Gcr2p likely functions as a co-activator in the
Gcr1p-Gcr2p complex.
To further understand the activation pathway from UAS
elements to gene expressions, we sought to isolate suppressors
of gcr2 mutants. Here we report on the identi¢cation of SGC1
as a multicopy suppressor of gcr2 mutants.
2. Materials and methods
2.1. Strains and media
Yeast strain 2845 (K leu2-3,112 ura3-52 his6) [17] was used as the
wild-type strain. MWGL29 (gcr1-6) [15], DFY643 (vgcr2-2: :URA3)
[15], and YHU3018 (vgcr1: :URA3, vgcr2-3F) [12] are derivatives of
2845. Heterozygous diploid strains C221 (a/K leu2-3,112/leu2-3,112
ura3-52/ura3-52 HIS6/his6 GCR1/vgcr1: :URA3) and C222 (a/K leu-
2-3,112/leu2-3,112 ura3-52/ura3-52 HIS6/his6 GCR2/vgcr2-3: :URA3)
were used for the disruption of SGC1. CTY10-5d (a ade2 trp1-901
leu2-3, 112 his3-200 vgal4 vgal80 URA3: :lexAop-lacZ), and its
derivatives CTY10-5dvgcr1 (vgcr1: :HIS3) [18] and CTY10-5dvgcr2
(vgcr2-3: :ADE2) were used for LexA-system experiments. Yeast cells
were transformed by the method of Ito et al. [19]. Plasmid DNA was
isolated from yeast by the method of Ho¡man and Winston [20].
Yeast strains were grown in rich medium [17] and synthetic complete
(SC) or SC dropout medium [21] depending on the plasmid markers.
Growth on plates was scored by measurements of colony size under a
microscope ¢tted with an ocular micrometer.
2.2. Plasmid constructions
A YEp13 base genomic DNA library (ATCC37323) was used to
screen for multicopy suppressor plasmids of the vgcr2 mutant. Plas-
mids (pD1420, pD1432 and pD1441) were independently isolated
from the library. pL1141-1 (SGC1/YEp351) was prepared by subclon-
ing a fragment from pD1420 into YEp351 [22]. It contains the SGC1
gene from 3654 bp 5P to the initiation codon (SacI site) to 98 bp
downstream of the termination codon (ScaI site). pL1152-4 (SGC1-1/
YEp351), an SGC1-1 mutant (E189 to Q) version, was created by PCR
based site-directed mutagenesis.
The following Sgc1p fusion plasmids were prepared for use in this
study by standard methods. LexA fusion plasmids were constructed
by using pBTM116 (LexA(1^202)), which resulted in the production
of hybrid polypeptides between LexA and Sgc1p. The moieties of each
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protein are indicated; pL1117-1 (LexA(1^202)/Sgc1p(11^291)) and
pL1179-54 (LexA(1^202)/Sgc1-1p(11^291)). Fusions of Sgc1p to the
DNA binding domain of Gcr1p are pL1308-16 (Sgc1p(1^208)/
Gcr1p(593^785)), pL1310-20 (Sgc1p(1^11)/Gcr1p(593^785)) and
pL1401-3 (Sgc1p(1^208)). A His-tag and Sgc1p fusion plasmid
pL1153-1 (His-tag/Sgc1p(11^291)) was constructed on pET-19b (No-
vagen).
For the disruption of SGC1, XhoI fragment (ca. 4 kb) of pD1420
was subcloned at the SalI site of pUC18 (pL1113-1), and the region
from BglII (at codon 11) to NcoI (at codon 208) was replaced with a
LEU2 marker (pL1119-1). To disrupt SGC1, pL1119-1 was digested
with HindIII and BamHI and the vsgc1: :LEU2 DNA fragment was
transformed into the diploid strains C221 (GCR1/vgcr1: :URA3) and
C222 (GCR2/vgcr2-3: :URA3). The proper disruptions were con-
¢rmed by PCR ampli¢cation of the integrated fragments. Detailed
description of plasmid constructions is available upon request.
2.3. Induction of the His-tag/Sgc1p fusion protein and its puri¢cation
Escherichia coli strain BL21(DE3)pLysS harboring His-tag/SGC1
fusion plasmid (pL1153-1) was grown at 37‡C in 100 ml of LB with
ampicillin and chloramphenicol to A600 of 0.5. Isopropyl-L-D-thioga-
lactopyranoside (IPTG) was added to a ¢nal concentration of 1 mM,
and the culture was grown for an additional 2 h at 37‡C. Cells were
collected by centrifugation, resuspended in 3 ml of binding bu¡er
(20 mM Tris^HCl, pH 7.9, 5 mM imidazol, 500 mM NaCl), and
disrupted by passage through a French pressure cell. After removing
the cell debris by centrifugation (17 000 rpm for 20 min), His-tag/
Sgc1p(11^291) was puri¢ed over a His-bind resin column (Novagen)
from the supernatant according to the protocol recommended by the
manufacturer.
2.4. In vitro footprinting studies
DNaseI footprints were carried out as described [2] with 0.06 U of
DNaseI (RQ1 DNase, Promega). The reaction mixtures were incu-
bated at room temperature for 2 min and the reaction was stopped
by adding an equal volume of stop solution (50% glycerol, 0.25 M
EDTA, pH 8.0). The resulting mixtures were subjected to a denatur-
ing sequencing gel electrophoresis after phenol extraction and ethanol
precipitation. Probes used for electromobility-shift and DNaseI foot-
print experiments are described in Fig. 1.
3. Results and discussion
3.1. Isolation of a multicopy suppressor gene of a vgcr2 mutant
To study the function of Gcr2p, we screened for multicopy
suppressors of the vgcr2 mutant. The gcr2 mutants grow
fairly well on glucose plates at 30‡C (semi-permissive condi-
tion), but their growth is severely impaired on glucose at 37‡C
in the presence of antimycin A (1 Wg/ml) (non-permissive con-
dition) [15]. Thus, a multicopy yeast genomic library was
transformed into the vgcr2-2 : :URA3 mutant (DFY643), and
Leu transformants were selected under the non-permissive
condition. Plasmid DNA was prepared from colonies with
substantial growth and retransformed into the original host
to con¢rm complementation.
The transformants of DFY643 harboring pD1420, pD1432
and pD1441 grew equally well under the non-permissive con-
dition. They contained di¡erent but overlapping inserts. The
smallest region in common spanned from nucleotide 975882
to 980111 of chromosome XV. The only ORF in this region
was SGC1. To further verify that the gene involved in the
suppression activity was SGC1, a fragment ranging from
654 bp upstream of the initiation codon (ATG) of SGC1 to
98 bp downstream of the termination codon was excised from
pD1420 and subcloned into YEp351. The resulting plasmid,
pL1141-1, suppressed the gcr2 mutation (compare Table 1,
line 4 with line 6), indicating SGC1 encoded the suppression
activity.
Since multicopy SGC1 could suppress gcr2 mutants, we
were interested if it could also suppress gcr1 mutation. There-
fore, we introduced pL1141-1 (SGC1/YEp351) into the gcr1
mutant MWGL29 and examined its growth on glucose plates.
However, SGC1 in multicopy (pL1141-1) was unable to sup-
press the gcr1 mutation (Table 1 line 7). Thus, while wild-type
Table 1
Growth and glycolytic enzyme activities of transformants
Line Host strain
(genotype)
Plasmid Relevant description Growth (colony size (mm))
on platesa
Relative enzyme activityb
SC(Glu)
(30‡C)
SC(GL)
(30‡C)
SC(Glu)+A
(37‡C)
Gpm Eno Pyk Zwf
1 2845 YEp351 Vector 1.2 0.6 1.1 (1.0) (1.0) (1.0) (1.0)
2 (WT) pL1141-1 SGC1 1.2 0.6 1.1 1.03 1.75 1.91 0.98
3 pL1152-4 SGC1-1 1.2 0.6 1.1 1.09 1.70 2.64 0.81
4 DFY643 pL1141-1 SGC1 0.8 0.3 0.8 0.36 0.42 0.31 1.14
5 (vgcr2-2: :URA3) pL1152-4 SGC1-1 0.8 0.3 1.0 0.33 1.02 0.69 0.97
6 YEp351 Vector 0.8 0.3 6 0.1 0.14 0.23 0.28 1.40
7 MWGL29 pL1141-1 SGC1 0.1 0.6 0.10 0.21 0.10 1.11
8 (gcr1-6) pL1152-4 SGC1-1 0.6 0.6 0.12 0.51 0.25 0.99
9 pL1308-16 Sgc1p(1^208)/Gcr1p(593^785) 0.9 0.6
10 pL1310-20 Sgc1p(1^11)/Gcr1p(593^785) 6 0.1 0.6
11 p1401-3 Sgc1p(1^208) 6 0.1 0.6
12 YEp351 Vector 0.1 0.6 0.074 0.14 0.16 1.14
13 YHU3018 pL1141-1 SGC1 0.2 0.6 0 0.028 0.12 0.075 1.43
14 (vgcr1: :URA3, pL1152-4 SGC1-1 0.8 0.6 0.2 0.063 0.36 0.34 1.11
15 vgcr2-3F) pL1308-16 Sgc1p(1^208)/Gcr1p(593^785) 1.0 0.6 0.5
16 pL1310-20 Sgc1p(1^11)/Gcr1p(593^785) 6 0.1 0.6 6 0.1
17 p1401-3 Sgc1p(1^208) 6 0.1 0.6 6 0.1
18 YEp351 Vector 6 0.1 0.6 6 0.1 0.015 0.064 0.068 1.43
aThe strains were streaked on synthetic drop-out plates (SC-Leu) containing 2% glucose (Glu), 2% glucose plus antimycin A (1 Wg/ml)
(Glu+A), or 2% glycerol plus 2% lactate (GL), and average colony size (mm) was measured after incubation at either 30‡C or 37‡C for 3 days.
bTransformants were grown to mid-log phase in synthetic medium containing 2% each of glycerol and lactate at 30‡C and glycolytic enzyme
assays were performed as described [15]. Values are normalized to those of the wild-type strain 2845. Speci¢c activities (in Wmol min31 mg
protein31) for the wild-type strains are 1.97 þ 0.18 for Gpm, 0.89 þ 0.11 for Eno, 0.57 þ 0.43 for Pyk and 0.19 þ 0.02 for Zwf.
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SGC1 in multicopy could relieve the requirement for Gcr2p, it
was unable to suppress gcr1.
Previously Nishi et al. [23] showed that a dominant muta-
tion allele of SGC1, SGC1-1, is able to suppress gcr1 muta-
tion. Thus we examined if the dominant allele SGC1-1 could
bypass the requirement of both gcr1 and gcr2. Accordingly we
introduced SGC1-1 (pL1152-4) into a gcr1, gcr2 double mu-
tant strain YHU3018 and the single mutants as well. In all
cases SGC1-1 suppressed the growth defects of the gcr mu-
tants (lines 5, 8 and 14). As assessed by colony size on glucose
plus antimycin A plates at 37‡C, SGC1-1 (pL1152-4) gives rise
to more robust growth of the gcr2 mutant than did SGC1
(pL1141-1) itself (compare line 4 with line 5). The enhanced
suppression activity was also con¢rmed in glycolytic enzyme
assays as described later.
3.2. SGC1 in multicopy restores glycolytic enzyme activities in
gcr2 mutants
To examine whether the suppression of the gcr2 mutation
by SGC1 was due to the restoration of glycolytic enzyme
activities, several glycolytic enzymes (phosphoglycerate mu-
tase (Gpm), enolase (Eno) and pyruvate kinase (Pyk)) were
assayed (Table 1). Transformants of gcr2 mutants with the
wild-type SGC1 (pL1141-1) displayed increased glycolytic en-
zyme activities while the activity of the control, non-glycolytic
enzyme glucose-6-P dehydrogenase (Zwf), which is una¡ected
in gcr1 and gcr2 mutants, was not a¡ected (compare line 4
with line 6). Thus, the suppression is associated with partial
restoration of the glycolytic enzyme activities. The suppres-
sion of gcr1 and gcr2 mutations by SGC1-1 was also associ-
ated with the restoration of glycolytic enzyme activities. The
e¡ect of SGC1-1 was more potent than that of SGC1 (lines 5
and 8). No di¡erences in growth of the wild-type were ob-
served when these genes were present in multicopy, but inter-
estingly, the wild-type strain 2845 harboring either SGC1 or
SGC1-1 in multicopy had higher activities of Eno and Pyk,
whereas the levels of Gpm were una¡ected (lines 2 and 3). It is
noteworthy that the recovery of Gpm activity was also small
in the suppression of the gcr1 mutant by SGC1-1 (line 8).
3.3. E¡ect of SGC1 disruption on the glycolytic enzyme
activities
To further address the role of SGC1 in glycolytic gene
expression, we disrupted SGC1. The sgc1 disruption
(vsgc1: :LEU2 DNA) was introduced into the diploid strains
C221 (GCR1/vgcr1: :URA3) and C222 (GCR2/vgcr2-
3: :URA3). The disruption of SGC1 was recessive, because
the diploid transformants grew normally. The diploid strains
were sporulated and dissected. Three tetra-type tetrads from
three independent transformants of each strain were analyzed.
The sgc1, GCR1 and sgc1, GCR2 strains were viable and had
a growth phenotype indistinguishable from the wild-type
strain (Table 2, lines 1, 2, 5 and 6). No e¡ect on the growth
phenotype was observed on other carbon sources (2% each of
fructose, mannose, sucrose, pyruvate, glycerol and 0.02% glu-
cose) (data not shown).
The null mutation of sgc1 moderately a¡ected the glycolytic
enzyme activities (Table 2, lines 2 and 6). The enzyme activ-
ities in sgc1, gcr1 and sgc1, gcr2 double mutants were lower
than for the respective gcr1 and gcr2 single mutants (lines 4
and 8). The growth phenotype of the sgc1, gcr2 double mu-
Fig. 1. Structure of the 5P-non-coding region of ENO1. The top bar
indicates the 5P-non-coding region of ENO1 from 3723 to 31. Nu-
cleotide positions are numbered relative to the translation initiation
codon (ATG). Positions of the putative E-boxes (E), UAS, TATA
sequence (T), mRNA initiation site (I), and relevant restriction en-
zyme sites are indicated. pL1131-3 and pL1145-1 were constructed
by cloning the 3120 to 3723 (603 bp) and 3402 to 3723 (321 bp)
regions of ENO1 5P non-coding region into the SmaI site of pT7/
T3K-19 (Gibco-BRL), respectively. The probes containing the ENO1
UAS element were excised from pL1131-3 either as a BamHI^EcoRI
fragment (624 bp) or NheI^EcoRI (140 bp) fragment and were used
as probes for electromobility-shift assays. The 772 bp NlaIV frag-
ment of pUC18, which contains no putative E-box sequence
(CANNTG), was used as a non-speci¢c competitor DNA. The 32P
labeled ends are indicated by asterisks and the regions analyzed by
in vitro footprinting experiments are indicated by arrows. Restric-
tion enzyme sites are: B, BamHI; E, EcoRI; H, HindIII; Nhe,
NheI; Sm, SmaI; Ssp, SspI. Restriction sites in the parentheses are
not conserved.
Table 2
Relative enzyme activities and growth characteristics of vsgc1 single, vsgc1,vgcr1 double and vsgc1,vgcr2 double mutants
Line Strain (genotype) Growth (colony size (mm)) on platesa Relative enzyme activityb
SC(Glu) SC(GL) SC(Glu)+A Gpm Eno Pyk Zwf
23‡C 30‡C 37‡C 23‡C 30‡C 37‡C 23‡C 30‡C 37‡C
1 WT 1.0 1.25 1.0 0.25 0.55 0.25 1.0 1.25 1.0 (1.0) (1.0) (1.0) (1.0)
2 vsgc1: :LEU2 1.0 1.25 1.0 0.25 0.5 0.25 1.0 1.25 1.0 0.62 0.44 0.69 0.78
3 vgcr1: :URA3 6 0.1 6 0.1 6 0.1 0.2 0.5 0.1 0 0 0 0.066 0.073 0.13 1.44
4 vgcr1: :URA3, vsgc1: :LEU2 6 0.1 6 0.1 6 0.1 0.2 0.4 0.1 0 0 0 0.011 0.047 0.071 1.20
5 WT 1.0 1.25 1.25 0.25 0.5 0.25 1.0 1.25 1.0 (1.0) (1.0) (1.0) (1.0)
6 vsgc1: :LEU2 1.0 1.25 1.25 0.2 0.5 0.25 0.7 1.25 1.0 0.71 0.52 0.87 1.08
7 vgcr2-3: :URA3 0.7 1.15 0.9 0.1 0.3 0.1 0.5 0.7 0.1 0.11 0.055 0.074 1.12
8 vgcr2-3: :URA3, vsgc1: :LEU2 0.5 1.0 0.25 6 0.1 0.3 6 0.1 0.2 0.25 0 0.10 0.038 0.028 0.88
Data in lines 1^4 and lines 5^8 are average of three complete sets of tetrads with tetra-type segregation which are derived from three independ-
ent transformants of C221 and C222 with vsgc1: :LEU2 DNA, respectively.
aSame as in Table 2.
bSame as in Table 2. Speci¢c activities for the wild-type strains are Gpm, 1.98 þ 0.28; Eno, 0.78 þ 0.10; Pyk, 2.10 þ 0.18 and Zwf, 0.25 þ 0.04
for line 1 and Gpm, 1.75 þ 0.26; Eno, 0.62 þ 0.16; Pyk, 1.28 þ 0.41 and Zwf, 0.26 þ 0.03 for line 5.
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tant was more impaired than the gcr2 mutant on glucose at
37‡C and on glucose at 30‡C in the presence of antimycin A
(lines 7 and 8). In contrast, we did not detect an additional
impairment in the sgc1, gcr1 double mutant to that associated
with gcr1 mutants (lines 3 and 4).
The phenotype of sgc1 disruptants is consistent with the
hypothesis that there is collaboration between Sgc1p and the
Gcr proteins. Since the e¡ect of the sgc1 disruption on glyco-
lytic gene expression was relatively small, it is quite likely that
Sgc1p functions in conjunction with the Gcr1p-Gcr2p com-
plex, but the possibility that Sgc1p works in a parallel path-
way still remains.
3.4. Intrinsic transcriptional function of Sgc1p
In light of our knowledge of Gcr2p function, we hypothe-
sized that Sgc1p may have a role in transcriptional activation.
Therefore, we used the LexA system to investigate this possi-
bility. We transformed plasmids encoding LexA/Sgc1p hy-
brids into the reporter strains CTY10-5d. lacZ Gene expres-
sion was weakly activated in transformants expressing the
LexA/Sgc1p fusion (pL1117-1), whereas Sgc1p without the
LexA moiety was not able to activate the reporter gene
(pL1141-1) (Table 3).
Does the intrinsic activating activity of Sgc1p require Gcr1p
or Gcr2p? To address this question, we introduced LexA/
Sgc1p hybrids into gcr3 derivatives of CTY10-5d. The gcr1
and gcr2 disruptions did not a¡ect the activity of the LexA/
Sgc1p fusion protein, indicating the transcriptional activity of
Sgc1p is independent of Gcr1p and Gcr2p. Unfortunately, we
could not examine the activation potential of the dominant
mutant Sgc1-1p in the LexA system, because we were unable
to obtain the desired transformant of plasmid pL1179-54
(LexA/Sgc1-1p). We hypothesized that the inability to isolate
the desired transformant was due to toxicity of Sgc1-1p when
overexpressed. Actually, we con¢rmed that the overexpression
of basic/helix-loop-helix (bHLH) region of Sgc1p was toxic
(data not shown).
Deletion mapping experiments suggested that function of
N-terminal region of Sgc1p is essential for its activation func-
tion (data not shown). To further address this point, we ex-
amined the complementation activity of Sgc1p/Gcr1p fusions.
Table 3
Transcriptional activation by the LexA/Sgc1p hybrid protein
Line Plasmid Description L-galactosidase activity (U)a in
CTY10-5d CTY10-5dvgcr1 CTY10-5dvgcr2
Glu GL Glu GL Glu GL
1 pL1117-1b LexA/Sgc1p(11^291)b 1.63 þ 0.57 3.82 þ 0.92 2.06 þ 0.09 3.08 þ 0.64 0.99 þ 0.07 3.76 þ 0.24
2 pL1141-1 Sgc1p(1^291) 0.05 þ 0.01 0.07 þ 0.01
3 pBTM116 LexA Vector 0.10 þ 0.02 0.40 þ 0.14 0.32 þ 0.01 0.42 þ 0.13 0.06 þ 0.01 0.20 þ 0.01
aTransformants were grown in 2% glucose (Glu), 2% lactate and 2% glycerol (GL) and assayed for L-galactosidase activity as described [14].
The values are average of three independent experiments.
bTransformants of LexA/Sgc1p(11^291) were weakly toxic.
Fig. 2. In vitro binding of Sgc1p to the 5P-non-coding region of
ENO1. Electromobility-shift analysis was carried out with radiola-
beled 5P-non-coding region (3723 to 3121) of ENO1. The probe
containing the 5P-non-coding region of ENO1 was incubated with
increasing amount of His-tag/Sgc1p(11^291). Standard DNA bind-
ing reaction was carried out with two-fold dilution series of an E.
coli produced and puri¢ed Sgc1p preparation (lanes 1^6). Lane 7
does not contain Sgc1p.
Fig. 3. Sgc1p protects the E-box sequence motif in the ENO1 5P-
non-coding region from DNaseI cleavage. DNaseI protection analy-
sis was carried out with puri¢ed His-tag/Sgc1p(11^291) and a radio-
labeled 624 bp fragment carrying 3723 to 3121 of the 5P-non-cod-
ing region of ENO1. Lanes 1^4: DNA fragments treated with 0, 1,
2 and 5 Wl of puri¢ed Sgc1p to form nucleoprotein complex were
treated with 0.06 U of DNaseI. The sequences of the protected area
and the position of the E-box are denoted on the right based on
the product of dideoxy sequencing reaction of pUC19 used as a mo-
lecular weight standard.
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The truncated Sgc1p (pL1401-3, Sgc1p(1^208)), which lacks
HLH region, did not suppress vgcr1 single and vgcr1, vgcr2
double mutant strains (Table 1, lines 11 and 17). However its
fusion to the DNA binding domain of Gcr1p (pL1308-16,
Sgc1p(1^208)/Gcr1p(593^785)) restored complementation ac-
tivity in both vgcr1 single and vgcr1, vgcr2 double mutant
strains (lines 9 and 15), whereas the DNA binding domain of
Gcr1p itself (pL1310-20, Sgc1p(1^11)/Gcr1p(593^785)) did
not (lines 10 and 16). This is an indication that the bHLH
region of Sgc1p provides DNA binding function and the es-
sential transcriptional activation function of Sgc1p resides in
the N-terminal region and once it is tethered to DNA, it can
provide activation function in Gcr1p and Gcr2p independent
manner.
3.5. Sgc1p is an E-box binding protein
The C-terminal region of Sgc1p exhibits strong similarity to
bHLH DNA binding motif of E-box binding proteins [23,24].
To assess Sgc1p’s DNA binding ability, we carried out DNA
electromobility-shift assays. Sgc1p was puri¢ed from E. coli as
a His-tag fusion protein, and the 5P non-coding region of
ENO1 (Fig. 1) was used as a probe. Fig. 2 shows the appear-
ance of a single major shifted band as an increasing amount
of Sgc1p was added to the binding reaction. To determine the
exact position where Sgc1p bound, we performed in vitro
DNaseI protection assays. Weak protection was observed
around the E-box region immediately upstream of the
TATA sequence by using a probe-A of Fig. 1 (Fig. 3). The
measurement of intensities of bands around the E-box con-
¢rmed the protection (data not shown). No other protections
were observed in this region by using probes -B and -C of
Fig. 1 (data not shown).
Sgc1p gave rise to a sequence speci¢c footprint albeit
weakly. Such observations are not uncommon for E-box pro-
teins. We carried out a series of DNA competition experi-
ments to determine the degree to which Sgc1p displays specif-
icity for its binding site. In a gel-shift assay with a probe
containing the footprinted E-box near the TATA sequence
of ENO1 (140 bp probe in Fig. 1), there was only an about
eight-fold di¡erence in competition between the speci¢c and
non-speci¢c competitors (3.5 nM (speci¢c) vs. 30 nM (non-
speci¢c)) (data not shown). This ¢nding was not unexpected,
since as a class, E-box binding proteins tend to bind DNA
with a low speci¢city. For example, the DNA binding specif-
icity of rat MASH-1 has a DNA binding speci¢city of less
than 10 [25] which is similar to the binding speci¢city we
measured for Sgc1p.
3.6. Conclusion
We identi¢ed SGC1 as a multicopy suppressor of gcr2 mu-
tants, and we showed that the suppression activity of SGC1 in
multicopy did not extend to gcr1 mutants. Previous work
identi¢ed a dominant mutant of SGC1, SGC1-1, as a suppres-
sor of gcr1 mutants [23]. We tested the prediction that Sgc1p
was an E-box DNA binding protein and showed that it was
capable of binding to an E-box in a sequence speci¢c manner,
but with a low degree of sequence speci¢city which is charac-
teristic of E-box binding proteins. We further showed that
Sgc1p has intrinsic transcriptional activation activity which
is independent of Gcr1p and Gcr2p, although the contribution
of Sgc1p to the overall level of glycolytic gene expression is
small when compared to that of Gcr1p or Gcr2p.
Considering the suppression characteristics of SGC1 and
SGC1-1 in relation to gcr1 and gcr2 mutants, we hypothesize
that the Gcr1p-Gcr2p activation complex at UAS elements
coordinates the binding of Sgc1p to E-box elements where
Sgc1p then contributes to the overall activation process of
the cognate genes.
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